2015: Infliximab or biosimilars in sarcoidosis; to switch or not to switch? Welke behandelstrategie volgt u bij switchen naar biosimilars?

2012: Behandeling van sarcoïdose met TNF-a blokkerende middelen: position paper NVALT

2011: Multidisciplinaire richtlijn ‘Verantwoord gebruik van biologicals’ 

Informatie biologicals 

Baughman RP, Lower EE, Drent M.
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them.
Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 76-89.

Salvana EMT, Cooper GS, Salata SA.
Mycobacterium other than tuberculosis (MOTT)infection: An emerging disease in infliximab-treated patients.
J Infection 2007; 55: 484-87.